The CLDF has established a hepatology committee dedicated to enhancing visibility and opportunities for women in the field of liver disease. The mission of this group is to cultivate and support a network of female colleagues, ultimately improving the lives of those affected by liver disease.
We gratefully acknowledge Intercept Pharmaceuticals as a founding sponsor of WHISE.
Steering Committee Members
Jihane Benhammou, MD
David Geffen School of Medicine at UCLA
Los Angeles, CA
Jessica Leigh Mellinger, MD, MSc
University of Michigan Health
Ann Arbor, MI
Kimberly A. Brown, MD, FAASLD, FAST, AGAF
Henry Ford Hospital
Detroit, MI
Nancy Reau, MD
Rush University Medical Center
Chicago, IL
Lily Dara, MD
Keck School of Medicine
University of Southern California
Los Angeles CA
Nicole Rich, MD
UT Southwestern Medical Center
Dallas, TX
Nadege T. Gunn, MD, CPI
Impact Research Institute
Waco, TX
Jessica Strzepka, MD
Rush University
Chicago, IL
Ani Kardashian, MD
Keck School of Medicine USC
Los Angeles, CA
Tram Tran, MD
UCLA Division of Digestive Diseases
Los Angeles, CA
Tatyana Kushner, MD, MSCE
Icahn School of Medicine at Mount Sinai
New York, NY
Kali Zhou, MD
Keck School of Medicine USC
Los Angeles, CA
Michelle Lai MD, MPH
Beth Israel Deaconess HealthCare
Boston, MA
Event
CLDF WHISE was pleased to host a Women in Hepatology Leadership Forum during the Liver Connect conference. Our event featured accomplished women leaders who shared their insights and experiences in leadership roles. The forum provided a valuable platform for networking and exchanging experiences. A key highlight was the emphasis on unity, mutual support among women, and the importance of shaping your career to balance a healthy work-life integration.